Nissay Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40,639
| Closed | -$1.15M | – | 725 |
|
|
2025
Q1 | $1.15M | Buy |
40,639
+562
| +1% | +$15.9K | 0.01% | 612 |
|
|
2024
Q4 | $1.61M | Sell |
40,077
-35,678
| -47% | -$1.43M | 0.01% | 569 |
|
|
2024
Q3 | $5.06M | Buy |
75,755
+6,722
| +10% | +$449K | 0.03% | 312 |
|
|
2024
Q2 | $8.2M | Buy |
69,033
+8,015
| +13% | +$952K | 0.05% | 215 |
|
|
2024
Q1 | $6.5M | Buy |
61,018
+16,236
| +36% | +$1.73M | 0.05% | 251 |
|
|
2023
Q4 | $4.45M | Buy |
44,782
+4,814
| +12% | +$479K | 0.04% | 284 |
|
|
2023
Q3 | $4.13M | Buy |
39,968
+1,597
| +4% | +$165K | 0.04% | 278 |
|
|
2023
Q2 | $4.66M | Buy |
38,371
+184
| +0.5% | +$22.4K | 0.04% | 250 |
|
|
2023
Q1 | $5.86M | Sell |
38,187
-1,811
| -5% | -$278K | 0.05% | 206 |
|
|
2022
Q4 | $7.18M | Sell |
39,998
-1,057
| -3% | -$190K | 0.07% | 173 |
|
|
2022
Q3 | $4.86M | Buy |
41,055
+1,050
| +3% | +$124K | 0.05% | 220 |
|
|
2022
Q2 | $5.72M | Sell |
40,005
-6,013
| -13% | -$859K | 0.06% | 192 |
|
|
2022
Q1 | $7.93M | Buy |
46,018
+860
| +2% | +$148K | 0.07% | 169 |
|
|
2021
Q4 | $11.5M | Buy |
45,158
+4,244
| +10% | +$1.08M | 0.09% | 141 |
|
|
2021
Q3 | $15.7M | Buy |
40,914
+7,425
| +22% | +$2.86M | 0.13% | 100 |
|
|
2021
Q2 | $7.87M | Buy |
33,489
+4,877
| +17% | +$1.15M | 0.07% | 166 |
|
|
2021
Q1 | $3.75M | Sell |
28,612
-636
| -2% | -$83.3K | 0.04% | 279 |
|
|
2020
Q4 | $3.06M | Buy |
29,248
+1,041
| +4% | +$109K | 0.05% | 310 |
|
|
2020
Q3 | $2M | Buy |
28,207
+632
| +2% | +$44.7K | 0.03% | 361 |
|
|
2020
Q2 | $1.77M | Buy |
+27,575
| New | +$1.77M | 0.03% | 395 |
|